Use of Anti VEGF agents in children
Statement from the College’s Paediatric Sub-committee; October 2014.
Choice of anti VEGF agents for wet AMD treatments
College statement on choice of two antiVEGF agents for the treatment of wet AMD, following NICE guidance on Ranibizumab (TA155) and Aflibercept (TA294). March2014